…
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was incorporated in 1999 and is headquartered in Tucson, Arizona.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Weed Inc (OTCQB: BUDZ) is an OTCQB-listed company with sparse public disclosure, and available filings do not provide a clear, verifiable description of its core cannabis-related operations. Investors may find exposure to the regulated cannabis market attractive; credible revenue generation, successful execution of licensing or retail initiatives, or strategic partnerships could support long-term growth.
The most important investment risks include thin trading liquidity typical of OTCQB microcaps, regulatory and sector volatility for cannabis businesses, and execution and financing risk that could hinder operational development.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1.37M | -0.51M | -0.03M | -1.53M | -2.84M |
| Net income | -1.37M | -0.51M | -0.03M | -1.53M | -2.84M |
| Selling general administrative | 1.31M | 0.51M | 0.72M | 1.39M | 2.67M |
| Gross profit | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Reconciled depreciation | 0.02M | 0.02M | 0.05M | 0.11M | 0.13M |
| Ebit | - | - | - | - | -2.80M |
| Ebitda | - | - | - | -1.30M | -2.67M |
| Operating income | -1.33M | -0.53M | -0.77M | -1.51M | -2.80M |
| Interest expense | 0.04M | 0.02M | 0.05M | 0.12M | 0.04M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Net interest income | -0.04M | -0.02M | -0.05M | -0.12M | -0.04M |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 1.33M | 0.53M | 0.77M | 1.51M | 2.80M |
| Cost of revenue | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Total other income expense net | -0.00M | 0.04M | 0.79M | 0.09M | -0.00M |
| Net income from continuing ops | -1.37M | -0.51M | -0.03M | -1.53M | -2.84M |
| Net income applicable to common shares | - | - | - | - | -2.84M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.56M | 0.74M | 0.90M | 1.63M | 1.96M |
| Intangible assets | 0.03M | 0.03M | 0.04M | 0.04M | 0.04M |
| Other current assets | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Total liab | 1.25M | 0.96M | 0.65M | 1.46M | 1.34M |
| Total stockholder equity | -0.69M | -0.22M | 0.26M | 0.17M | 0.62M |
| Other current liab | - | - | - | - | 0.00M |
| Common stock | - | - | - | - | 0.12M |
| Capital stock | 0.15M | 0.13M | 0.12M | 0.12M | 0.12M |
| Retained earnings | -86.28M | -84.90M | -84.39M | -84.36M | -82.83M |
| Cash | 0.03M | 0.16M | 0.29M | 0.32M | 0.02M |
| Total current liabilities | 1.25M | 0.96M | 0.65M | 1.46M | 1.34M |
| Net debt | 0.47M | 0.26M | - | 0.39M | 0.64M |
| Short long term debt | 0.50M | 0.42M | 0.14M | 0.71M | 0.66M |
| Other stockholder equity | - | - | - | - | 0.35M |
| Property plant equipment | - | - | - | - | 1.88M |
| Total current assets | 0.05M | 0.19M | 0.32M | 0.34M | 0.04M |
| Net tangible assets | - | - | - | - | 0.58M |
| Net receivables | - | - | - | - | 0.00M |
| Accounts payable | 0.18M | 0.17M | 0.18M | 0.19M | 0.25M |
| Non current assets total | 0.51M | 0.55M | 0.58M | 1.29M | 1.92M |
| Capital lease obligations | 0.00M | 0.02M | 0.03M | 0.04M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.00M | 1.63M | 1.26M | -0.27M |
| Change to liabilities | - | - | - | - | 0.00M |
| Total cashflows from investing activities | - | - | - | - | -0.27M |
| Net borrowings | 0.07M | 0.28M | -0.59M | - | 0.29M |
| Total cash from financing activities | 0.07M | 0.29M | -0.59M | -0.15M | 0.85M |
| Change to operating activities | - | - | - | - | 0.12M |
| Net income | -1.37M | -0.51M | -0.03M | -1.53M | -2.84M |
| Change in cash | -0.13M | -0.13M | -0.03M | 0.30M | 0.01M |
| Begin period cash flow | 0.16M | 0.29M | 0.32M | 0.02M | 0.01M |
| End period cash flow | 0.03M | 0.16M | 0.29M | 0.32M | 0.02M |
| Total cash from operating activities | -0.20M | -0.42M | -1.07M | -0.81M | -0.57M |
| Issuance of capital stock | - | - | 0.00M | 0.04M | 0.56M |
| Depreciation | 0.02M | 0.02M | 0.05M | 0.11M | 0.13M |
| Change to netincome | - | - | - | - | 2.02M |
| Capital expenditures | 0.00M | 0.00M | 0.01M | 0.00M | 0.27M |
| Change in working capital | 0.24M | 0.03M | -0.23M | 0.03M | 0.12M |
| Stock based compensation | 0.80M | 0.02M | 0.00M | 0.00M | 2.00M |
| Other non cash items | 0.12M | 0.03M | 0.13M | 0.67M | 0.02M |
| Free cash flow | -0.20M | -0.42M | -1.08M | -0.81M | -0.84M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| BUDZ Weed Inc |
0.00 6.38% |
0.02 | - | - | - | 671.71 | 53.83 |
| MKKGY Merck KGaA ADR |
0.40 1.22% |
33.13 | 21.25 | 14.93 | 3.10 | 2.14 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
169.65 | 24.86 | 15.11 | 3.13 | 1.98 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
- -% |
21.64 | - | 10.96 | 0.01 | 1.20 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.15 | - | 10.66 | 0.01 | 1.16 | 23.11 |
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was incorporated in 1999 and is headquartered in Tucson, Arizona.
| Name | Title | Year Born |
|---|---|---|
| Mr. Glenn E. Martin | Co-Founder, Chairman, Pres, CEO, CFO & Chief Accounting Officer | 1954 |
| Ms. Nicole M. Breen | Co-Founder, Sec., Treasurer & Director | 1976 |
| Mr. Patrick Brodnik | Managing Director of WEED Australia Ltd. | NA |
| Mr. Glenn E. Martin | Co-Founder, Chairman, President, CEO, CFO & Chief Accounting Officer | 1954 |
| Ms. Nicole M. Breen | Co-Founder, Secretary, Treasurer & Director | 1976 |
| Mr. Elliot Kwestel | MD, Director & Corporate Secretary of WEED Israel (Cannabis) Ltd. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.